Gene: KDM4F
Official Full Name: lysine demethylase 4Fprovided by HGNC
Gene Summary: Predicted to enable histone H3K9 demethylase activity. Predicted to be involved in chromatin remodeling and regulation of gene expression. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16791 | KDM4F Knockout cell line (HeLa) | Human | KDM4F | 1:3~1:6 | Negative | Online Inquiry |
KO16792 | KDM4F Knockout cell line (HCT 116) | Human | KDM4F | 1:2~1:4 | Negative | Online Inquiry |
KO16793 | KDM4F Knockout cell line (A549) | Human | KDM4F | 1:3~1:4 | Negative | Online Inquiry |
KDM4F Gene Knockout Cell Lines are a powerful tool for researchers aiming to study the role of the KDM4F gene in various biological processes, particularly in epigenetic regulation and gene expression. These specialized cell lines have been engineered to exhibit a complete loss of function of the KDM4F gene, which encodes a histone demethylase involved in the removal of methylation marks from histones H3 and H4. The knockout methodology, typically achieved through CRISPR-Cas9 technology, leads to significant alterations in chromatin dynamics and cellular signaling pathways, providing crucial insights into gene regulation mechanisms.
The primary function of KDM4F is to influence gene expression by modulating the epigenome, an essential process for cellular differentiation and response to environmental stimuli. By utilizing these knockout cell lines, researchers can effectively dissect the contributions of KDM4F to cellular phenotypes, including differentiation status in stem cells, cancer progression, and responses to therapeutics. In clinical settings, understanding KDM4F function could lead to new strategies for treating diseases associated with dysregulated epigenetic modifications, particularly various cancers.
What sets KDM4F Gene Knockout Cell Lines apart from traditional models is their targeted gene disruption, which minimizes off-target effects and enhances consistency in experimental outcomes. These lines are optimized for high viability and ease of manipulation, facilitating the integration of various experimental protocols, including drug response assays, transcriptional profiling, and signaling pathway analysis.
The value of KDM4F Gene Knockout Cell Lines lies in their potential to accelerate research discoveries and advance personalized medicine approaches. By utilizing these cell lines, researchers and clinicians can gain a deeper understanding of the complexities of gene regulation and its implications in health and disease. With our company’s commitment to providing high-quality biological products backed by extensive expertise in gene editing and cell line development, we ensure that our customers receive reliable and innovative tools to enhance their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.